JPMorgan Chase & Co Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| 1 |
JPMorgan International Research Enhanced Equity ETF
JIRE
|
+$4.15B |
| 2 |
Microsoft
MSFT
|
+$2.17B |
| 3 |
UnitedHealth
UNH
|
+$1.8B |
| 4 |
Amazon
AMZN
|
+$1.7B |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$1.41B |
Top Sells
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$4.17B |
| 2 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.58B |
| 3 |
iShares Short Treasury Bond ETF
SHV
|
+$659M |
| 4 |
Financial Select Sector SPDR Fund
XLF
|
+$627M |
| 5 |
CERN
Cerner Corp
CERN
|
+$608M |
Sector Composition
| 1 | Technology | 16% |
| 2 | Healthcare | 13.32% |
| 3 | Financials | 11.15% |
| 4 | Consumer Discretionary | 8.38% |
| 5 | Industrials | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2901
Avidity Biosciences
RNA
$5.92B
| $1.84M | ﹤0.01% |
126,582
+25,467
| +25% | +$370K |
|
2902
Carpenter Technology
CRS
$12.3B
| $1.84M | ﹤0.01% |
65,864
-59,939
| -48% | -$1.67M |
|
2903
OrthoPediatrics
KIDS
$501M
| $1.84M | ﹤0.01% |
42,612
+36,063
| +551% | +$1.56M |
|
2904
Stem
STEM
$146M
| $1.84M | ﹤0.01% |
12,826
+7,805
| +155% | +$1.12M |
|
2905
Vanguard ESG US Stock ETF
ESGV
$11.5B
| $1.84M | ﹤0.01% |
27,645
+3,465
| +14% | +$230K |
|
2906
OR Royalties Inc.
OR
$6.7B
| $1.83M | ﹤0.01% |
181,594
-108,645
| -37% | -$1.1M |
|
2907
Park National Corp
PRK
$2.74B
| $1.83M | ﹤0.01% |
15,114
+1,375
| +10% | +$167K |
|
2908
GrowGeneration
GRWG
$103M
| $1.83M | ﹤0.01% |
508,401
+130,086
| +34% | +$467K |
|
2909
Intrepid Potash
IPI
$380M
| $1.82M | ﹤0.01% |
40,128
+34,389
| +599% | +$1.56M |
|
|
WAVC
2910
DELISTED
Waverley Capital Acquisition Corp. 1
WAVC
| $1.82M | ﹤0.01% |
188,000
-11,000
| -6% | -$106K |
|
2911
Dimensional US Targeted Value ETF
DFAT
$11.9B
| $1.82M | ﹤0.01% |
45,125
+44,986
| +32,364% | +$1.81M |
|
|
AZUL
2912
DELISTED
Azul
AZUL
| $1.8M | ﹤0.01% |
253,682
+24,539
| +11% | +$174K |
|
2913
Domo
DOMO
$730M
| $1.8M | ﹤0.01% |
64,676
-56,866
| -47% | -$1.58M |
|
2914
iShares Russell Top 200 ETF
IWL
$1.85B
| $1.8M | ﹤0.01% |
20,000
| – | – |
|
2915
Laureate Education
LAUR
$4.35B
| $1.79M | ﹤0.01% |
155,080
-73,416
| -32% | -$849K |
|
2916
Horace Mann Educators
HMN
$1.89B
| $1.79M | ﹤0.01% |
46,665
-112,769
| -71% | -$4.33M |
|
2917
Agilon Health
AGL
$493M
| $1.79M | ﹤0.01% |
81,974
-176,177
| -68% | -$3.84M |
|
2918
Dynavax Technologies
DVAX
$1.15B
| $1.78M | ﹤0.01% |
141,570
+58,671
| +71% | +$739K |
|
2919
AppFolio
APPF
$10.1B
| $1.78M | ﹤0.01% |
19,641
+3,682
| +23% | +$334K |
|
|
CTEV
2920
Claritev Corporation
CTEV
$931M
| $1.78M | ﹤0.01% |
8,105
+1,311
| +19% | +$288K |
|
|
CNDA
2921
DELISTED
Concord Acquisition Corp II
CNDA
| $1.78M | ﹤0.01% |
184,431
-142,896
| -44% | -$1.38M |
|
2922
Passage Bio
PASG
$23.4M
| $1.78M | ﹤0.01% |
37,630
-1,247
| -3% | -$58.9K |
|
2923
8x8 Inc
EGHT
$301M
| $1.77M | ﹤0.01% |
344,542
+123,539
| +56% | +$636K |
|
|
AUTL
2924
Autolus Therapeutics
AUTL
$354M
| $1.77M | ﹤0.01% |
626,519
-173,039
| -22% | -$490K |
|
2925
LSB Industries
LXU
$606M
| $1.77M | ﹤0.01% |
127,850
+29,661
| +30% | +$411K |
|